Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. letters
  3. article
Preparation of Cæruloplasmin from the G2 Fraction of Human Plasma
Download PDF
Download PDF
  • Letter
  • Published: 14 March 1959

Preparation of Cæruloplasmin from the G2 Fraction of Human Plasma

  • G. CURZON1 &
  • L. VALLET2 

Nature volume 183, page 751 (1959)Cite this article

  • 310 Accesses

  • 2 Citations

  • Metrics details

Abstract

THE recent publication of a communication on the preparation of cæruloplasmin1, the main cuproprotein of plasma, prompts this brief account of a method of its preparation from the precipitate G2, the mixture of α- and β-globulins obtained in the plasma fractionation scheme of Kekwick and Mackay2. With G2 from batches of plasma of 40–150 l., the following stages were used: (1) Extraction of G2 by 0.07 M sodium chloride at pH7 and denaturation of extracted lipoprotein with ether below − 25° C. by the McFarlane technique3; (2) precipitation of cæruloplasmin from the ether-saturated extract at pH 4.8; (3) solution of the precipitate in ether-saturated 0.1 M sodium chloride, removal of impurities by precipitation at pH 5.35 and a second McFarlane treatment; (4) reprecipitation of cæruloplasmin at pH 4.8 as in (2) and solution in 0.1 M sodium chloride; (5) precipitation of impurities at pH 4.8 by diluting to 0.02 M sodium chloride and precipitation of cæruloplasmin by further dilution to 0.0045 M sodium chloride. The product was dissolved in 0.l M sodium chloride. E 1 cm. (605 mµ)/E 1 cm. (280 mµ), which gives a measure of degree of purification, was 0.019.

Similar content being viewed by others

A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor

Article Open access 25 November 2020

New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia

Article Open access 30 January 2024

A quantitative method for determination of colistin E2 methanesulphonate in human plasma by 15N-labeled colistin E2

Article Open access 26 October 2023

Article PDF

References

  1. Steinbuch, M., and Quentin, M., Nature, 183, 323 (1959).

    Article  ADS  CAS  Google Scholar 

  2. Kekwick, R. A., and Mackay, M. E., Medical Research Council Spec. Rep. No. 286 (1954).

  3. McFarlane, A. S., Nature, 149, 439 (1942).

    Article  ADS  CAS  Google Scholar 

  4. Morell, A. G., and Scheinberg, I. H., Science, 127, 588 (1958).

    Article  ADS  CAS  Google Scholar 

  5. Litt, M., and Boyd, W. C., Nature, 181, 1075 (1958).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemical Pathology, Institute of Neurology, London, W.C.1.

    G. CURZON

  2. Blood Products Laboratory, Lister Institute, Elstree, Herts.

    L. VALLET

Authors
  1. G. CURZON
    View author publications

    Search author on:PubMed Google Scholar

  2. L. VALLET
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

CURZON, G., VALLET, L. Preparation of Cæruloplasmin from the G2 Fraction of Human Plasma. Nature 183, 751 (1959). https://doi.org/10.1038/183751a0

Download citation

  • Issue date: 14 March 1959

  • DOI: https://doi.org/10.1038/183751a0

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • News
  • Opinion
  • Research Analysis
  • Careers
  • Books & Culture
  • Podcasts
  • Videos
  • Current issue
  • Browse issues
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Staff
  • About the Editors
  • Journal Information
  • Our publishing models
  • Editorial Values Statement
  • Journal Metrics
  • Awards
  • Contact
  • Editorial policies
  • History of Nature
  • Send a news tip

Publish with us

  • For Authors
  • For Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature (Nature)

ISSN 1476-4687 (online)

ISSN 0028-0836 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing